We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




PET Imaging Reveals Brain Benefits from Weight Loss After Bariatric Surgery

By HospiMedica International staff writers
Posted on 31 Aug 2014
Imaging studies revealed that weight loss surgery has been found to suppress changes in brain metabolism associated with obesity and improve cognitive function involved in planning, strategizing, and organizing. More...
Therefore, researchers have hypothesized that a specific surgical procedure could reduce risk of Alzheimer’s in obese people.

The findings were published online August 26, 2014, in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). Obesity can overload the brain as well as other organs and obese individuals face a 35% higher risk of developing Alzheimer’s disease compared to normal weight people. Bariatric surgery is used for individuals who are severely obese lose weight by restricting the amount of food they can eat before feeling satiated by reducing the stomach’s size or limit the absorption of nutrients by removing part of the small intestine from the path food takes through the digestive tract. Some procedures, such as Roux-en-Y gastric bypass (RYBG) surgery, use a combination of these techniques. This study was the first to assess brain activity in women before and after bariatric surgery.

“When we studied obese women prior to bariatric surgery, we found some areas of their brains metabolized sugars at a higher rate than normal weight women,” said one of the study’s authors, Cintia Cercato, MD, PhD, from the University of Sao Paolo (Brazil). “In particular, obesity led to altered activity in a part of the brain linked to the development of Alzheimer’s disease—the posterior cingulate gyrus. Since bariatric surgery reversed this activity, we suspect the procedure may contribute to a reduced risk of Alzheimer’s disease and other forms of dementia.”

The longitudinal study examined the effect of RYBG surgery on the brain function of 17 obese women. Researchers used positron emission tomography (PET) imaging scans and neuropsychologic tests to evaluate brain function and activity in the participants prior to surgery and six months after the procedure. The same tests also were run once on a control group of 16 lean women.

The obese women, before undergoing surgery, had higher rates of metabolism in specific regions of the brain, including the posterior cingulate gyrus. Following surgery, there was no evidence of this exacerbated brain activity. Their brain metabolism rates were comparable to the activity seen in normal weight women. After surgery, the obese women also performed better on a test gauging executive function than they did before the procedures. Executive function is used in planning, organizing, and strategizing. Five other neuropsychologic tests measuring various aspects of memory and cognitive function demonstrated no change following the surgery.

“Our findings suggest the brain is another organ that benefits from weight loss induced by surgery,” Dr. Cercato concluded. “The increased brain activity the obese women exhibited before undergoing surgery did not result in improved cognitive performance, which suggests obesity may force the brain to work harder to achieve the same level of cognition.”

Related Links:

University of Sao Paolo



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Workflow for the volumetric atria models generation. From left to right, creation of the statistical shape model (SSM) instance, volume generation and labeling of anatomical and electrophysiological regions, generation of interatrial connections, design of fiber orientation, and design of atrial cardiomyopathy (ACM) patterns (Macarulla-Rodríguez, M., Sánchez, J., Barrios Espinosa, C. et al. Discovery Computing (2026). https://doi.org/10.1007/s10791-026-10439-9)

Noninvasive AI Tool Maps Atrial Cardiomyopathy to Support Ablation Planning

Atrial cardiomyopathy involves electrical and structural abnormalities in atrial tissue, including fibrosis, and is linked to atrial fibrillation. Identifying affected tissue can help clinicians understand... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.